Governance - Committee Composition

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet

Below is a summary of our committee structure and membership information.

Chairperson Chairperson Committee Member Member Audit committee financial expert Financial Expert
 BoardAudit and RiskCompensationNominating and Corporate Governance
David  W. Anstice* 
David  W. Anstice*

Mr. Anstice has been a director of Alkermes since October 2008. From 2006 to 2008, he served as Executive Vice President of Merck & Co., Inc. with responsibility for enterprise strategy and implementation. During two separate parts of this period he was acting President, Global Human Health and President of Merck’s business in Japan. From 2003 to 2006, Mr. Anstice served as President of Merck, with responsibility for Merck’s Asia Pacific businesses. In his 34 years with Merck, he held a variety ... 
Committee Member   Chairperson  
Floyd E. Bloom* 
Floyd E. Bloom*

Dr. Bloom is a founder of Alkermes and has been a director of Alkermes since 1987. Dr. Bloom has been active in neuropharmacology for more than 35 years, holding positions at Yale University, the National Institute of Mental Health and The Salk Institute. From 1983 to February 2005, Dr. Bloom was the Chairman of the Neuropharmacology Department at The Scripps Research Institute and is currently Professor Emeritus. Dr. Bloom served as Editor-in-Chief of Science from 1995 to May 2000. He holds an ... 
Committee Member Committee Member   
Robert A. Breyer* Audit committee financial expert
Robert A. Breyer*

Mr. Breyer has been a director of Alkermes since July 1994. He served as the President of Alkermes from July 1994 until his retirement in December 2001 and Chief Operating Officer from July 1994 to February 2001. From August 1991 to December 1993, Mr. Breyer was President and General Manager of Eli Lilly Italy, a subsidiary of Eli Lilly and Company. From September 1987 to August 1991, he was Senior Vice President, Marketing and Sales of IVAC Corporation, a subsidiary of Eli Lilly and Company. Mr... 
Committee Member Committee Member   Committee Member
Wendy L.  Dixon* 
Wendy L.  Dixon*

Dr. Dixon has been a director of Alkermes since January 2011. She has extensive experience in the pharmaceutical and biotech industry, combining a technical background with experience in drug development, regulatory affairs and marketing. She directed the launch of and growth of more than 20 pharmaceutical products. From 2001 to 2009 she was Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb where she served on the Executive Committee. From 1996 to 2001 she was Seni... 
Committee Member    Chairperson
Paul J. Mitchell*+ Audit committee financial expert
Paul J. Mitchell*+

Mr. Mitchell has been a director of Alkermes since April 2003. He served as the Chief Financial Officer and Treasurer of Kenet, Inc. from 2002 until 2009. Prior to joining Kenet, Mr. Mitchell was the Chief Financial Officer and Treasurer of Kopin Corporation from April 1985 through September 1998. From September 1998 through June 2001, Mr. Mitchell served in a consulting role at Kopin as Director of Strategic Planning. Prior to joining Kopin, Mr. Mitchell worked for the international accounting ... 
Committee Member Chairperson Committee Member  
Richard F. Pops 
Richard F. Pops
Chairman and Chief Executive Officer

Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in 1991. Under his leadership, Alkermes has grown from a privately held company with 25 employees to an international, publicly traded biopharmaceutical company with more than 2,000 employees. Alkermes has a diversified commercial product portfolio and a substantial clinical pipeline of central nervous system (CNS) product candidates. Mr. Pops currently serves on the Value and Coverage Advisory Cou... 
Nancy L. Snyderman* 
Nancy L. Snyderman*

Dr. Snyderman has been a director of Alkermes since May 2016. She most recently served as Chief Medical Editor at NBC News, and has more than three decades of experience as a leading voice in healthcare and medicine. Dr. Snyderman is a board certified Otolaryngologist-Head and Neck Surgeon and Fellow in the American College of Surgeons. She currently serves on the Board of Directors of GE’s Healthymagination. Dr. Snyderman is a board member of the Institute for Healthcare Improvement in Cambridg... 
Committee Member    
Nancy J. Wysenski* 
Nancy J. Wysenski*

Ms. Wysenski has been a director of Alkermes since May 2013. From December 2009 through June 2012, Ms. Wysenski served as the Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals Inc. Under her leadership, the commercial organization grew from 40 to 400 employees and the company’s first two product launches occurred. Prior to joining Vertex, Ms. Wysenski held the position of Chief Operating Officer of Endo Pharmaceuticals, where she led sales, marketing, commercial ope... 
Committee Member   Committee Member Committee Member

* denotes Independent Directors
+ denotes Lead Independent Director